Brief: Statera Biopharma Announces Pricing Of $2.0 Mln Registered Direct Offering
07/02/2022 04:01
Feb 6 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA ANNOUNCES PRICING OF $2.0 MILLION
REGISTERED
DIRECT OFFERING
* CO HAS AGREED TO SELL APPROXIMATELY 2.0 MILLION SHARES OF
ITS
COMMON STOCK AND WARRANTS
* PURCHASE PRICE FOR ONE SHARE OF COMMON STOCK AND ONE
WARRANT
WILL BE $1.00
Source text for Eikon: ID:nGNXrhrq7
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc